Danaher Corporation income statement

In fiscal 2025, Danaher Corporation reported revenue of $24.57bn, up 2.9% on the year before, operating income of $4.69bn (a 19.1% margin) and net income of $3.61bn, or $5.05 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Danaher Corporation: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	10.5	12.6	16.1	18.3	18.3	12.9	14.4	16.9	18.3	19.9	17.9	22.3	24.8	26.6	23.9	23.9	24.6	25.6
Cost of revenue	5.4	6.1	7.9	8.8	8.9	6.0	6.7	7.5	6.9	7.5	7.9	9.8	9.6	10.5	9.9	9.7	10.0	10.6
Gross profit	5.1	6.4	8.2	9.4	9.3	6.8	7.8	9.3	8.6	9.5	10.0	12.5	15.2	16.2	14.0	14.2	14.5	15.0
Research and development	0.6	0.8	1.0	1.1	1.1	0.8	0.9	1.0	1.0	1.1	1.1	1.3	1.5	1.5	1.5	1.6	1.6	1.7
Selling, general and administrative	3.1	3.6	4.6	5.2	5.1	4.0	4.7	5.6	5.0	5.4	5.6	6.9	6.8	7.1	7.3	7.8	8.2	8.1
Operating income	1.4	2.0	2.6	3.2	3.1	2.0	2.2	2.7	2.6	3.1	3.3	4.2	6.4	7.5	5.2	4.9	4.7	5.2
Interest expense	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.3	0.4
Income before tax	1.3	2.2	2.4	3.0	3.4	2.1	2.0	2.6	2.5	3.0	3.3	4.5	6.5	7.1	5.0	4.6	4.2	4.8
Income tax	0.2	0.5	0.5	0.7	0.8	0.4	0.3	0.5	0.4	0.6	0.9	0.8	1.1	0.8	0.8	0.7	0.6	0.5
Net income	1.2	1.8	2.2	2.4	2.7	2.6	3.4	2.6	2.5	2.7	3.0	3.6	6.4	7.2	4.8	3.9	3.6	4.3
Diluted EPS	$1.73	$2.64	$3.11	$3.36	$3.80	$3.63	$4.74	$3.65	$3.53	$3.74	$4.05	$4.89	$8.61	$9.66	$6.38	$5.29	$5.05	$6.11
Diluted shares (average)	671m	683m	701m	713m	711m	716m	709m	700m	706m	710m	726m	719m	737m	737m	743m	737m	716m	709m
EBITDA	1.8	2.4	3.3	4.0	4.0	2.8	3.0	3.9	3.7	4.2	4.5	6.0	8.4	9.7	7.4	5.6	5.4	6.0

US$ millions unless shown otherwise. Fiscal quarters.

Danaher Corporation: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	6,538	5,741	5,936	6,053	6,838	5,951	6,265	6,554
Cost of revenue	2,648	2,230	2,413	2,530	2,872	2,360	2,654	2,717
Gross profit	3,890	3,511	3,523	3,523	3,966	3,591	3,611	3,837
Research and development	442	379	403	378	438	387	412	433
Selling, general and administrative	2,023	1,858	2,360	1,991	2,026	1,860	2,072	2,159
Operating income	1,425	1,274	760	1,154	1,502	1,344	1,127	1,245
Interest expense	61	72	71	67	55	63	107	135
Income before tax	1,315	1,129	655	1,076	1,373	1,235	1,078	1,132
Income tax	229	175	100	168	190	206	208	−75
Net income	1,086	954	555	908	1,197	1,029	870	1,235
Diluted EPS	$1.49	$1.32	$0.77	$1.27	$1.68	$1.45	$1.23	$1.75
EBITDA	1,612	1,455	945	1,343	1,697	1,537	1,323	1,453

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DHR vs IQV DHR vs TMO DHR vs ICLR

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Danaher Corporation's SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Danaher Corporation.